Old Web
English
Sign In
Acemap
>
Paper
>
The Impact of Biosimilar Launch on Molecule Price and Pharmaceutical Expense: The Case of the Insulin Glargine in Italy
The Impact of Biosimilar Launch on Molecule Price and Pharmaceutical Expense: The Case of the Insulin Glargine in Italy
2017
A. Tettamanti
L. Cioni
C. Tucci
Keywords:
Biosimilar
Intensive care medicine
Marketing
Insulin glargine
Economics
Pharmacology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]